Cart
0

Insomnia Market by Therapy Type [Non-pharmacological Therapy (Hypnotherapy, Cognitive Behavioral Therapy, Medical Devices, and Other Non-pharmacological Therapy) and Pharmacological Therapy (Prescription Sleep Aids and Over-The-Counter Sleep Aids)] - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_172373
Pages: 120
Jun 2017 | 3052 Views
 
Author's : Onkar Sumant and Tenzin Kunsel
Tables: 48
Charts: 26
 

Insomnia Market Overview:

Global Insomnia Market was valued at $4,093 million in 2016, and is estimated to reach $5,488 million by 2023, registering a CAGR of 4.2% from 2017 to 2023. Insomnia is a sleep disorder where in the person faces difficultly to sleep or remain asleep. The symptoms include low stamina, daytime sleepiness, depression, and irritability. It is a highly prevalent disorder that affects millions of people, worldwide. Insomnia-related conditions are caused due to disruption in circadian rhythm, chronic pain, hyperthyroidism, menopause, psychological stress, and other medical conditions. Moreover, excessive use of drugs, such as caffeine, alcohol, and nicotine could lead to insomnia. This disorder can be diagnosed in sleep laboratories using various diagnostic devices. Depending on the duration of the disorder, insomnia is divided into three types, namely transient, acute, and chronic insomnia. In transient insomnia, the symptoms persist from a few days to a few weeks; acute insomnia persists for several weeks; and chronic insomnia last for months to a few years.

Global Insomnia Market Segmentation

GLOBAL INSOMNIA MARKET SEGMENTATION

 

Get more information on this report : Request Sample Pages

The global insomnia market is segmented based on therapy type and geography. Based on therapy type, it is bifurcated into non-pharmacological and pharmacological therapy. Non-pharmacological therapy is further categorized into hypnotherapy, cognitive behavioral therapy, medical devices, and other non-pharmacological therapy. Pharmacological therapy is further divided into prescription sleep aids and over-the-counter sleep aids. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Drivers, Restraints, and Opportunities

The impact of the driving factors is expected to surpass the effect of restraints. Moreover, technological advancements have led to higher adoption rate and untapped markets in the developing economies are expected to provide new avenues for the growth of the insomnia market in the near future.

Drivers and Restraints

INSOMNIA MARKET DRIVERS AND RESTRAINTS

 

Get more information on this report : Request Sample Pages

 

Global Insomnia Market: Key Geographical Segments

North America accounted for the highest market share in the insomnia market in 2016, and is expected to maintain its dominance throughout the forecast period.

Global Insomnia Market, by Region, 2016 (%)

GLOBAL INSOMNIA MARKET, BY REGION, 2016 (%)

Get more information on this report : Request Sample Pages

 

The key players operating in the global insomnia market include Merck & Co. Inc., Sanofi, Pfizer, Inc., Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare Inc., Pernix Therapeutics, Vanda Pharmaceuticals, and ECR Pharmaceuticals.

The other prominent players in the value chain include Fidia Farmaceutici, Dainippon Sumitomo, Biocodex, Eli Lilly and Company, and Ebb Therapeutics.

Key Benefits

  • This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to therapy type and geography.
  • In-depth analysis based on geography assists in understanding the regional market to assist in strategic business planning.
  • The growth strategies adopted by key manufacturers assist in understanding the competitive scenario of the market.

Insomnia Market Key Segments:

By Therapy Type

  • Non-pharmacological Therapy
    • Hypnotherapy
    • Cognitive Behavioral Therapy
    • Medical Devices
    • Other Non-pharmacological Therapy
  • Pharmacological Therapy
    • Prescription Sleep Aids
    • Over-the-counter Sleep Aids

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Republic of South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Emergence of therapeutics with fewer side-effects
3.5.1.2. Rise in demand for OTC sleep aids
3.5.1.3. Stressful work condition and working in shifts

3.5.2. Restraints

3.5.2.1. Side Effects of Drugs
3.5.2.2. Rise in number of patent expiration of branded prescription drugs

3.5.3. Opportunities

3.5.3.1. Untapped Markets in Developing Economies
3.5.3.2. Presence of Large Undiagnosed Insomnia Population Pool

Chapter: 4 INSOMNIA MARKET, BY THERAPY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. NON-PHARMACOLOGICAL THERAPY

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Hypnotherapy
4.2.5. Cognitive Behavioral Therapy
4.2.6. Medical Devices
4.2.7. Other Non-pharmacological Therapy

4.3. PHARMACOLOGICAL THERAPY

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Prescription sleep aids
4.3.5. Over-the-counter sleep aids

Chapter: 5 INSOMNIA MARKET, BY GEOGRAPHY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Mexico market size and forecast
5.2.3.3. Canada market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. UK market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. Germany market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. India market size and forecast
5.4.3.2. Japan market size and forecast
5.4.3.3. China market size and forecast
5.4.3.4. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. Brazil market size and forecast
5.5.3.2. South Africa market size and forecast
5.5.3.3. Saudi Arabia market size and forecast
5.5.3.4. Rest of LAMEA market size and forecast

Chapter: 6 COMPANY PROFILES

6.1. MERCK & CO. INC.

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Business performance
6.1.5. Key strategic moves and developments

6.2. SANOFI

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Business performance
6.2.5. Key strategic moves and developments

6.3. PFIZER, INC.

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Business performance
6.3.5. Key strategic moves and developments

6.4. TAKEDA PHARMACEUTICAL COMPANY LTD.

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Business performance
6.4.5. Key strategic moves and developments

6.5. PURDUE PHARMACEUTICALS L.P.

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Business performance
6.5.5. Key strategic moves and developments

6.6. EISAI, CO. LTD.

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Business performance
6.6.5. Key strategic moves and developments

6.7. MEDA CONSUMER HEALTHCARE INC.

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Business performance
6.7.5. Key strategic moves and developments

6.8. PERNIX THERAPEUTICS

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Business performance
6.8.5. Key strategic moves and developments

6.9. VANDA PHARMACEUTICALS

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Business performance
6.9.5. Key strategic moves and developments

6.10. ECR PHARMACEUTICALS

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Business performance
6.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL INSOMNIA MARKET, BY THERAPY TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL INSOMNIA MARKET BY NON-PHARMACOLOGICAL THERAPY, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. GLOBAL INSOMNIA MARKET BY NON-PHARMACOLOGICAL THERAPY, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL INSOMNIA MARKET BY HYNOTHERAPY THERAPY, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL INSOMNIA MARKET BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL INSOMNIA MARKET BY MEDICAL DEVICES, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL INSOMNIA MARKET BY OTHER NON-PHARMACOLOGICAL THERAPY, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL INSOMNIA MARKET BY PHARMACOLOGICAL THERAPY, BY TYPE, 2016-2023 ($MILLION)
TABLE 9. GLOBAL INSOMNIA MARKET BY PHARMACOLOGICAL THERAPY, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL INSOMNIA MARKET BY PRESCRIPTION SLEEP AIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL INSOMNIA MARKET BY OVER-THE-COUNTER SLEEP AIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 12. INSOMNIA MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 13. NORTH AMERICA INSOMNIA MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 14. NORTH AMERICA INSOMNIA MARKET, BY THERAPY TYPE, 2016-2023 ($MILLION)
TABLE 15. NORTH AMERICA INSOMNIA MARKET, BY NON-PHARMACOLOGICAL THERAPY, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA INSOMNIA MARKET, BY PHARMACOLOGICAL THERAPY, 2016-2023 ($MILLION)
TABLE 17. EUROPE INSOMNIA MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18. EUROPE INSOMNIA MARKET, BY THERAPY TYPE, 2016-2023 ($MILLION)
TABLE 19. EUROPE INSOMNIA MARKET, BY NON-PHARMACOLOGICAL THERAPY, 2016-2023 ($MILLION)
TABLE 20. EUROPE INSOMNIA MARKET, BY PHARMACOLOGICAL THERAPY, 2016-2023 ($MILLION)
TABLE 21. ASIA-PACIFIC INSOMNIA MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 22. ASIA-PACIFIC INSOMNIA MARKET, BY THERAPY TYPE, 2016-2023 ($MILLION)
TABLE 23. ASIA-PACIFIC INSOMNIA MARKET, BY NON-PHARMACOLOGICAL THERAPY, 2016-2023 ($MILLION)
TABLE 24. ASIA-PACIFIC INSOMNIA MARKET, BY PHARMACOLOGICAL THERAPY, 2016-2023 ($MILLION)
TABLE 25. LAMEA INSOMNIA MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 26. LAMEA INSOMNIA MARKET, BY THERAPY TYPE, 2016-2023 ($MILLION)
TABLE 27. LAMEA INSOMNIA MARKET, BY NON-PHARMACOLOGICAL THERAPY, 2016-2023 ($MILLION)
TABLE 28. LAMEA INSOMNIA MARKET, BY PHARMACOLOGICAL THERAPY, 2016-2023 ($MILLION)
TABLE 29. MERCK: COMPANY SNAPSHOT
TABLE 30. MERCK: OPERATING SEGMENTS
TABLE 31. SANOFI: COMPANY SNAPSHOT
TABLE 32. SANOFI: OPERATING SEGMENTS
TABLE 33. PFIZER: COMPANY SNAPSHOT
TABLE 34. PFIZER: OPERATING SEGMENTS
TABLE 35. TAKEDA: COMPANY SNAPSHOT
TABLE 36. TAKEDA: OPERATING SEGMENTS
TABLE 37. PURDUE: COMPANY SNAPSHOT
TABLE 38. PURDUE: OPERATING SEGMENTS
TABLE 39. EISAI: COMPANY SNAPSHOT
TABLE 40. EISAI: OPERATING SEGMENTS
TABLE 41. MEDA: COMPANY SNAPSHOT
TABLE 42. MEDA: OPERATING SEGMENTS
TABLE 43. PERNIX: COMPANY SNAPSHOT
TABLE 44. PERNIX: OPERATING SEGMENTS
TABLE 45. VANDA: COMPANY SNAPSHOT
TABLE 46. VANDA: OPERATING SEGMENTS
TABLE 47. ECR: COMPANY SNAPSHOT
TABLE 48. ECR: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. SEGMENTATION OF GLOBAL INSOMNIA MARKET
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL INSOMNIA MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF NEW ENTRANTS
FIGURE 9. THREAT OF SUBSTITUTION
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. RESTRAINTS AND DRIVERS: GLOBAL INSOMNIA MARKET
FIGURE 12. GLOBAL INSOMNIA MARKET: PRODUCT SEGMENTATION
FIGURE 13. U.S. INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 15. CANADA INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 16. UK INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 17. FRANCE INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 18. GERMANY INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 19. INDIA INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 20. JAPAN INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 21. CHINA INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 22. REST OF ASIA-PACIFIC INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 23. BRAZIL INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 24. SOUTH AFRICA INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 25. SAUDI ARABIA INSOMNIA MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF LAMEA INSOMNIA MARKET, 2016-2023 ($MILLION)

 

Insomnia is a sleep disorder caused due to various factors such as stressful lifestyle, mental disorders, and other medical conditions, consumption of certain drugs, caffeine, and alcohol also cause insomnia. The therapeutic techniques differ with the type of insomnia affecting the quality of sleep of the patient. The types of insomnia differ with the duration the disorder, such as: transient (persist for few days), acute (few weeks), and chronic (few months).

The rise in demand for over-the-counter (OTC) sleep aids and emergence of therapeutics with fewer side-effects drive the market growth. In addition, rise in geriatric population and growth in the incidence rate of chronic diseases are increased the use of therapeutics for treating insomnia. Furthermore, the rise in stress level among youth due to factors such as job stress and intense competition have led to surge in the incidence rate of insomnia. However, the side-effects caused due to excessive use of sleep medication and patent expiration of various prescription drugs are expected to restrict the market growth.

Non-pharmacological therapy segment is expected to be lucrative for new entrants and existing market players, as this form of treatment causes fewer side-effects as compared to sleep medications. Furthermore, cognitive behavioral therapy is expected to be the fastest growing segment in the near future, as these therapies help to identify and change the thought and behavior that causes insomnia in a patient. Moreover, in this technique, therapeutic approach can be modified as per the needs of patients.

The use of insomnia treatment is highest in North America, owing to increase in adoption of these therapies, high prevalence rate of insomnia, and rise in disposable income among customers. Although the use of therapies for the treatment of insomnia is low in Asia-Pacific and LAMEA, the adoption rate is expected to increase due to rise in disposable income, increase in incidence rate of insomnia, and surge in the number of people working at odd hours.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Insomnia Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo